Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European Industry Calls For Move From Principles To Action On ePI

Trade Bodies Have Advocated For ePI Inclusion In Upcoming EU Legislation

Executive Summary

A survey of hospital pharmacists across Europe has found that the majority of the profession finds electronic product information beneficial, but technological shortcomings can act as a barrier to access.

You may also be interested in...



EU Prepares To Pilot Electronic Product Information

The adoption of a new common standard opens the way to the implementation of EU-wide electronic formats for documents such as the summary of product characteristics and the patient information leaflet.

Full Electronic Product Information In EU May Have To Wait Until 2030

A wide-ranging survey by Europe’s research-based pharma industry says moves towards replacing paper product information are gathering pace, although numerous challenges will need to be overcome.

European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform

The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.

Topics

Latest News
See All
UsernamePublicRestriction

Register

GB151694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel